Skip to content
NATCO50mg

Drawing based on the description in the official product monograph. No photo yet.

“50 mg capsules: Yellow to orange colored granular powder filled in Size '2' hard gelatin capsules with caramel opaque cap and caramel opaque body, printed with white ink "NATCO" on cap and "50 mg" on body.. Composition NAT-SUNITINIB capsules are supplied as printed hard-shell capsules containing sunitinib malate equivalent to 12.5, 25, or 50 mg of sunitinib together with mannitol, microcrystalline”

NATCO 50 mg pill

Pill with imprint NATCO 50 mg is brown & yellow, capsule and has been identified as Sunitinib Malate 50 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Natco Pharma (Canada) Inc.

Sold in Canada

Sunitinib Malate 50 mg

Brand
Nat-Sunitinib
Imprint
NATCO 50 mg
Strength
50 mg
Used for
Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
Color
Brown, Yellow
Shape
Capsule / oblong
Form
Capsule
Manufacturer
Natco Pharma (Canada) Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02539284

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Sunitinib Malate pills and guides

What is Sunitinib Malate used for?

Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Gastrointestinal Stromal Tumor

Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.

Advanced Renal Cell Carcinoma

Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).

Adjuvant Treatment of Renal Cell Carcinoma

Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.

Advanced Pancreatic Neuroendocrine Tumors

Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows NATCO 50 mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is brown & yellow, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Nat-Sunitinib by Natco Pharma (Canada) Inc.

In Canada: prescription only.

Ingredients

Active: Sunitinib (Sunitinib Malate)

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Sunitinib Malate pills